Alivus Life Sciences

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue594.11515.41652.30659.64610.84
Expenses443.87387.95467.16468.34447.85
EBITDA164.98142.89200.77208.52181.29
EBIT150.59127.80185.61192.55164.23
Profit Before Tax150.24127.46185.15191.29162.99
Net Profit111.4895.32136.96141.87121.54
Financial Ratios
Operating Profit Margin28.03%28.19%31.28%32.10%30.12%
Net Profit Margin18.94%18.81%21.34%21.84%20.19%
Earning Per Share (Diluted)9.087.7511.1411.559.88
Dividends Per Share0.000.000.000.000.00